List of articles with "North Chicago"

AbbVie Q3 Financial Report

2026-10-30 12:03:29

USA AbbVie North Chicago Skyrizi RINVOQ

BLA Submission for Etentamig

2026-10-27 12:14:01

United States Multiple Myeloma AbbVie North Chicago Etentamig

SKYRIZI Approval

2026-10-23 19:36:12

USA Crohn's Disease AbbVie North Chicago Skyrizi

Hidradenitis Suppurativa Breakthrough

2026-10-22 14:03:58

United States AbbVie North Chicago Hidradenitis Lutikizumab

Cancer Breakthrough

2026-10-20 05:31:38

USA AbbVie North Chicago DLBCL Genmab

Zika Virus Against Glioblastoma

2026-10-19 20:25:13

USA Glioblastoma North Chicago UP Oncolytics Zika Virus

ABBV-466 Promises

2026-10-19 08:09:42

USA Crohn's Disease AbbVie North Chicago ABBV-466

AbbVie at ESMO 2026

2026-10-18 22:26:33

United States oncology AbbVie North Chicago ESMO 2026

AbbVie IBD Efficacy Insights

2026-10-17 06:08:13

USA AbbVie North Chicago Skyrizi RINVOQ

AbbVie SKYRIZI Results

2026-10-13 19:21:48

USA Crohn's Disease AbbVie North Chicago Skyrizi

Menopause and Alzheimer’s Risk

2026-10-09 22:50:13

USA Alzheimer's Disease Women's Health North Chicago Rosalind Franklin University

New Provost at RFU

2026-10-08 18:46:29

United States North Chicago healthcare education Rosalind Franklin University James Carlson

FDA Breakthrough Designations

2026-10-07 13:13:27

United States AbbVie North Chicago Telisotuzumab Temab-A

AbbVie EMA Approval

2026-10-06 05:59:28

United States Crohn's Disease AbbVie North Chicago Risankizumab

Epcoritamab Study Success

2026-10-05 18:58:35

USA Epcoritamab AbbVie North Chicago DLBCL

Saros Therapeutics Award

2026-10-02 16:08:22

United States North Chicago Helix 51 RFU Saros Therapeutics

RINVOQ® and Vitiligo Insights

2026-10-01 14:28:16

USA AbbVie North Chicago RINVOQ Vitiligo

AbbVie atogepant results

2026-10-01 04:28:26

United States AbbVie North Chicago Atogepant menstrual migraine

AbbVie Phase 1 Results

2026-09-30 09:50:13

United States AbbVie North Chicago ABBV-295 EASD 2026

AbbVie’s Zumilokibart Results

2026-09-30 05:37:19

United States AbbVie North Chicago Zumilokibart EADV

AbbVie at EADV 2026

2026-09-30 05:06:37

United States dermatology AbbVie North Chicago EADV2026

Entenamig Trial Success

2026-09-28 04:29:29

United States AbbVie North Chicago Entenamig CERVINO

COVID-19 and Adolescent Brains

2026-09-24 18:14:11

United States North Chicago COVID-19 Rosalind Franklin University Adolescent Mental Health

AbbVie & Iambic Team Up

2026-09-21 12:16:53

United States AI Technology AbbVie North Chicago Iambic

Innovative Virtual Health System

2026-09-18 14:14:04

USA Medical Training North Chicago healthcare education Virtual Health System

AbbVie Presents Etentamig Data

2026-09-17 12:39:08

USA AbbVie North Chicago Myeloma Etentamig

AbbVie and PGA TOUR Unite

2026-09-15 12:53:23

USA AbbVie North Chicago PGA Tour Birdies for Brain Health

AbbVie Quarterly Dividend

2026-09-10 18:24:22

United States Dividend Stockholders AbbVie North Chicago

Etentamig Shows Promise

2026-09-03 13:39:37

United States Multiple Myeloma AbbVie North Chicago Etentamig

AbbVie Acquires Apogee

2026-09-03 12:39:51

United States AbbVie North Chicago Immunology Apogee Therapeutics

Layered Beauty Report

2026-09-02 12:16:12

United States AbbVie North Chicago Allergan Aesthetics Layered Beauty

New EVP for Research at RFU

2026-08-27 17:22:20

United States Research North Chicago Rosalind Franklin University Narayanan Parameswaran

AbbVie Seeks SKYRIZI EMA Approval

2026-08-27 06:10:30

United States Crohn's Disease AbbVie North Chicago Skyrizi

AbbVie Upadacitinib Approval

2026-08-25 05:26:29

United States AbbVie North Chicago Upadacitinib Vitiligo

AbbVie Lung Cancer Insights

2026-08-21 11:47:47

United States AbbVie North Chicago Lung Cancer WCLC 2026

AbbVie Scholarships 2026

2026-08-18 12:21:06

USA North Chicago AbbVie Immunology Scholarship chronic inflammatory diseases higher education support

Epcoritamab Approval

2026-08-05 01:20:30

United States Epcoritamab AbbVie North Chicago Relapsed Follicular Lymphoma

Innovative Biomarkers for Military Health

2026-07-31 21:13:13

United States North Chicago Military Health Rosalind Franklin University Bone-Stress Injuries

AbbVie Q2 Report

2026-07-31 11:51:15

United States AbbVie North Chicago Skyrizi RINVOQ

JUVÉDERM® Day Returns

2026-07-30 12:19:03

USA North Chicago Allergan Aesthetics JUVÉDERM® Day Allē

Resankizumab FDA Approval

2026-07-22 04:31:43

United States AbbVie North Chicago Pediatrics Resankizumab

Risankizumab Approval

2026-07-22 04:31:27

United States Psoriasis AbbVie North Chicago Risankizumab

Epcoritamab Trial Results

2026-07-15 05:20:02

United States Epcoritamab North Chicago DLBCL Lenalidomide

AbbVie EHA 2026 Insights

2026-07-07 04:46:07

United States AbbVie North Chicago EHA 2026 hematologic cancer

AbbVie Venetoclax Update

2026-06-30 05:26:57

USA North Chicago Chronic Lymphocytic Leukemia venetoclax EHA 2026

Phase 3 Trial Results

2026-06-29 21:00:16

USA Epcoritamab AbbVie North Chicago DLBCL

Epcoritamab Phase 3 Results

2026-06-29 20:28:55

United States Epcoritamab AbbVie North Chicago DLBCL

AbbVie Advances Alopecia Treatment

2026-06-29 07:16:13

USA AbbVie North Chicago Alopecia Areata Upadacitinib

AbbVie's New Treatment

2026-06-29 07:15:42

USA AbbVie North Chicago RINVOQ Upadacitinib

Upadacitinib for Vitiligo

2026-06-29 07:05:07

USA AbbVie North Chicago Upadacitinib Vitiligo